Skip to main content

Table 1 Baseline characteristics of Indigenous adults in 19 communities from North Queensland 1998–2000 by albuminuria at baseline

From: Albuminuria and its associated biomedical factors among indigenous adults in Far North Queensland: a 7-year follow up study

 

Albuminuria No = 1582

Albuminuria Yes = 389

Total N = 1971

 

Mean or % (95% CI)

Mean or % (95% CI)

Mean or % (95% CI)

Age (Years) *

36.8 (36.1-37.5)

46.5 (45.0-48.0)

38.7 (38.1-39.4)

Female %

50.6 (48.2-53.1)

48.8 (43.9-53.8)

50.3 (48.1-52.5)

Aboriginal % *

54.0 (51.5-56.4)

43.4 (38.6-48.4)

51.9 (49.7-54.1)

WC (CM) *

95.8 (95.0-96.6)

104.4 (102.8-106.0)

97.5 (96.8-98.2)

Abdominal overweight and obesity * %

  

Overweight

19.6 (17.5-21.8)

19.0 (14.8-23.9)

19.5 (17.6-21.5)

Obesity

41.4 (38.8-44.1)

58.3 (52.5-63.8)

44.4 (42.0-46.8)

BMI (kg/m2) *

27.8 (27.5-28.1)

30.4 (29.6-31.1)

28.3 (28.0-28.6)

BMI % *

   

25-29.9

27.0 (24.9-29.3)

25.2 (21.1-29.9)

26.7 (24.8-28.7)

> = 30

34.4 (32.1-36.8)

50.9 (45.9-55.9)

37.7 (35.5-39.8)

SBP (mmHg) *

129.2 (128.3-130.1)

140.8 (138.7-142.8)

131.5 (130.6-132.3)

DBP (mmHg) *

71.0 (70.3-71.7)

77.5 (76.2-78.8)

72.3 (71.7-72.9)

Hypertension % *

26.4 (24.3-28.6)

49.9 (44.9-54.8)

31.0 (29.0-33.1)

Glucose (mmol/L) *

5.5 (5.4-5.7)

7.0 (6.7-7.4)

5.8 (5.7-6.0)

Diabetes % *

12.4 (10.9-14.1)

35.2 (30.6-40.1)

16.9 (15.3-18.6)

Cholesterol (mmol/L) *

4.97 (4.92-5.02)

5.13 (5.02-5.24)

5.00 (4.96-5.05)

Triglycerides (mmol/L) *

1.87 (1.79-1.94)

2.12 (1.95-2.29)

1.92 (1.85-1.99)

HDL (mmol/L)

1.12 (1.11-1.14)

1.18 (1.15-1.20)

1.13 (1.12-1.15)

Dyslipidaemia %

46.8 (44.3-49.3)

49.5 (44.4-54.5)

47.3 (45.1-49.5)

GGT (IU) *

50.2 (47.0-53.4)

57.5 (51.6-63.3)

51.6 (48.8-54.5)

GGT > 50 % *

28.7 (26.5-31.0)

38.2 (33.4-43.2)

30.6 (28.5-32.7)

Smoker % *

60.4 (58.0-62.8)

49.2 (44.3-54.2)

58.2 (56.0-60.4)

Drinking status %

   

Moderate

23.4 (21.4-25.6)

20.4 (16.6-24.7)

22.8 (21.0-24.7)

Risky

49.3 (46.8-51.8)

46.8 (41.8-51.9)

48.8 (46.6-51.1)

PA sufficient %

25.6 (23.5-27.8)

18.8 (15.2-23.0)

24.3 (22.4-26.2)

  1. *P < 0.05 from ttest or chi square test or corresponding non-parametric tests
  2. Abdominal overweight was defined using WHO criteria as WC greater than 80 cm in females and 94 cm in males and obesity as greater than 88 cm in female and 102 in male
  3. Hypertension was ascertained either by detection of high BP at examination (measured BP > =140/90 (mmHg) or previous confirmed diagnosis or currently prescribed antihypertensive medication (by medical record review)
  4. Diabetes was defined as either clinical diagnosis verified by the participants’ medical records or a 2 hour oral glucose tolerance test, or fasting blood glucose level >7.0 mmol/L
  5. Dyslipidaemia was defined as having triglycerides > =2.0 mmol/L or HDLC <1.0 mmol/L recommended by National Heart Foundation
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us